Hjem › Behandlingsresistent depressiv lidelse › Washington
Behandlingsresistent depressiv lidelse kliniske forsøg i Washington
4 studier for Behandlingsresistent depressiv lidelse søger deltagere på steder i Washington.
Byer i Washington
Officiel studietekst (engelsk)
A Study of Esketamine Nasal Spray Versus Placebo Spray in Adult Participants With Treatment-resistant Depression
- Northwest Clinical Research Center, Bellevue
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 25. sep. 2026 · NCT07716098A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression
- Center For Anxiety and Depression, Mercer Island
- Seattle Neuropsychiatric Treatment Center, Seattle
Rekrutterer
Alder 18 og opefter · Alle køn · Opdateret 15. jun. 2026 · NCT03887715A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)
- Seattle Neuropsychiatric Treatment Center, Bellevue
RekruttererFase 2
Alder 18 til 65 · Alle køn · Opdateret 11. maj 2026 · NCT06524830ALTO-207 in Adults With Treatment-resistant Depression (TRD)
- Site 7128, Seattle
RekruttererFase 2
Alder 18 til 75 · Alle køn · Opdateret 28. apr. 2026 · NCT07553637Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.